ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105827 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105827; 2) Community: the network communities that were significantly associated with the response to NSC 105827; 3) Molecule: the relationships between components within communities and NSC 105827; 4) MDR: the compounds that were significantly associated with the NSC 105827.

NSC Compound Enrichment Correlation
NSC 682825 Propanimidoyl chloride, N-[[[(4-bromophenyl)amino] carbonyl]oxy]-2-methyl- 0.0105972823829604 0.38502978
NSC 714604 Purpureagitosid 0.0105972823829604 -0.16575749
NSC 740476 Null 0.0105972823829604 0.27548418
NSC 619042 Cyclohexanone, 2,6-bis[(dimethylamino)methyl]-, dihydrochloride 0.0119221520283057 0.41151858
NSC 630684 8-Quinolinecarboxaldehyde, 2-(2,4-dinitrophenyl)-2-methyl- hydrazone 0.0119221520283057 -0.35663228
NSC 72942 DL-Noformicin 0.0119221520283057 -0.0058099669
NSC 733301 Null 0.0119221520283057 0.25370955
NSC 305767 2,4-Quinazolinediamine, 6-[(4-chlorophenyl)thio]- 0.0122129861493296 0.14534625
NSC 674964 Spiro[s-indacene-2(1H),2'-[2H]indene]-8-carboxylic acid, 3,5,6,7,1',3'-hexahydro-3'-oxo- 0.0122129861493296 0.27548252
NSC 678102 4H-1-Benzopyran-4-one, 2-(1,3-benzodioxol-5-yl)-5-hydroxy-3,7-dimethoxy- 0.0122129861493296 -0.36360518
Total:55  Current:12    [First] [Prev] [Next] [Last]